241 N Stock Overview
An investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Alibaba Health Information Technology Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$13.54 |
| 52 Week High | HK$0 |
| 52 Week Low | HK$0 |
| Beta | 0.99 |
| 1 Month Change | 0% |
| 3 Month Change | -6.81% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -77.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| 241 N | MX Consumer Retailing | MX Market | |
|---|---|---|---|
| 7D | 0% | -3.8% | -2.9% |
| 1Y | n/a | -14.8% | -14.0% |
Return vs Industry: Insufficient data to determine how 241 N performed against the MX Consumer Retailing industry.
Return vs Market: Insufficient data to determine how 241 N performed against the MX Market.
Price Volatility
| 241 N volatility | |
|---|---|
| 241 N Average Weekly Movement | n/a |
| Consumer Retailing Industry Average Movement | 3.7% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in MX Market | 6.0% |
| 10% least volatile stocks in MX Market | 2.6% |
Stable Share Price: 241 N has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 241 N's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 1,581 | Shunyan Zhu | www.alihealth.cn |
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. It offers range of prescription drugs, over-the-counter drugs, nutritional supplements, medical devices, contact lenses, and various other health-related products through its online stores on Tmall.com and offline pharmacy outlets to business-to-customer and business-to-business customers; and pharmaceutical products, medical devices and healthcare products, health food, sexual health and family planning products, contact lenses, and medical and healthcare services through its e-commerce platform. The company also provides medical and healthcare services, including medical checkups, nucleic acid testing, medical consultation, registration, vaccination, and TCM through various channels, such as Taobao, Tmall, Alipay, Dr. Deer APP, Gaode, DingTalk, and Quark.
Alibaba Health Information Technology Limited Fundamentals Summary
| 241 N fundamental statistics | |
|---|---|
| Market cap | Mex$152.96b |
| Earnings (TTM) | Mex$320.72m |
| Revenue (TTM) | Mex$57.43b |
476.9x
P/E Ratio2.7x
P/S RatioIs 241 N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 241 N income statement (TTM) | |
|---|---|
| Revenue | CN¥22.72b |
| Cost of Revenue | CN¥18.18b |
| Gross Profit | CN¥4.54b |
| Other Expenses | CN¥4.41b |
| Earnings | CN¥126.88m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
May 23, 2023
| Earnings per share (EPS) | 0.0094 |
| Gross Margin | 19.97% |
| Net Profit Margin | 0.56% |
| Debt/Equity Ratio | 0% |
How did 241 N perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/05/15 03:25 |
| End of Day Share Price | 2023/02/15 00:00 |
| Earnings | 2022/09/30 |
| Annual Earnings | 2022/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Alibaba Health Information Technology Limited is covered by 30 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xiaomeng Zhuang | BofA Global Research |
| Shun Kei Law | CCB International Securities Limited |
| Hazim Bahari | CFRA Equity Research |